Why the study?
Worsening serum creatinine is common during acute decompensated heart failure treatment, but whether it is driven by diuresis-induced hemoconcentration versus filtration changes was uncertain.
Does hemoconcentration (change in volume of distribution) contribute to changes in serum creatinine during diuresis for acute decompensated heart failure?
Does hemoconcentration (change in volume of distribution) contribute to changes in serum creatinine during diuresis for acute decompensated heart failure?
During the treatment of acute decompensated heart failure, increases in serum creatinine are driven predominantly by changes in filtration rather than hemoconcentration.
Answers are grounded in this paper and cite their sources.
Creatinine changes during ADHF diuresis are minimally attributable to hemoconcentration; leaves open filtration as primary driver pending prospective validation.
Key Points Hemoconcentration is a minimal contributor to changes in serum creatinine during treatment of decompensated heart failure. Changes in GFR is the primary driver of serum creatinine in treatment of decompensated heart failure. Background Worsening serum creatinine is common during treatment of acute decompensated heart failure (ADHF). A possible contributor to creatinine increase is diuresis-induced changes in volume of distribution (VD) of creatinine as total body water (TBW) contracts around a fixed mass of creatinine. Our objective was to better understand the filtration and nonfiltration factors driving change in creatinine during ADHF. Methods Participants in the ROSE-AHF trial with baseline to 72-hour serum creatinine; net fluid output; and urinary KIM-1, NGAL, and NAG were included ( n =270). Changes in VD were calculated by accounting for measured input and outputs from weight-based calculated TBW. Changes in observed creatinine (Cr observed ) were compared with predicted changes in creatinine after accounting for alterations in VD and non–steady state conditions using a kinetic GFR equation (Cr 72HR Kinetic ). Results When considering only change in VD, the median diuresis to elicit a ≥0.3 mg/dl rise in creatinine was −7526 ml (IQR, −5932 to −9149). After accounting for stable creatinine filtration during diuresis, a change in VD alone was insufficient to elicit a ≥0.3 mg/dl rise in creatinine. Larger estimated decreases in VD were paradoxically associated with improvement in Cr observed ( r =−0.18, P =0.003). Overall, −3% of the change in eCr 72HR Kinetic was attributable to the change in VD. A ≥0.3 mg/dl rise in eCr 72HR Kinetic was not associated with worsening of KIM-1, NGAL, NAG, or postdischarge survival ( P >0.05 for all). Conclusions During ADHF therapy, increases in serum creatinine are driven predominantly by changes in filtration, with minimal contribution from change in VD.
No takes yet. Share an insight, caveat, or question.
Maulion et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: